Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor T Cells: The Intersection of Stem Cells and Immunotherapy
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor T Cells: The Intersection of Stem Cells and Immunotherapy
Authors
Keywords
-
Journal
Cellular Reprogramming
Volume 25, Issue 5, Pages 195-211
Publisher
Mary Ann Liebert Inc
Online
2023-10-03
DOI
10.1089/cell.2023.0041
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antigen‐specific TCR‐T cells from Rag2 gene‐deleted pluripotent stem cells impede solid tumour growth in a mouse model
- (2023) Bingyan Wu et al. CELL PROLIFERATION
- An HLA-homozygous haplobank resource to promote safer cell therapies
- (2023) Glyn Nigel Stacey Cell Stem Cell
- Nanobodies in cell-mediated immunotherapy: On the road to fight cancer
- (2023) Amirhosein Maali et al. Frontiers in Immunology
- Advancing cell-based cancer immunotherapy through stem cell engineering
- (2023) Yan-Ruide Li et al. Cell Stem Cell
- Unraveling barriers to iPSC-derived CAR-T cell differentiation
- (2023) Sjoukje J.C. van der Stegen et al. Cell Stem Cell
- Natural killer cell epigenetic reprogramming in tumors and potential for cancer immunotherapy
- (2023) Tahereh Hojjatipour et al. Epigenomics
- New cell sources for CAR-based immunotherapy
- (2023) Marzieh Mazinani et al. Biomarker Research
- Chimeric antigen receptor-natural killer cells: a promising sword against insidious tumor cells
- (2023) Tahereh Hojjatipour et al. Human Cell
- CAR-T Regulatory (CAR-Treg) Cells: Engineering and Applications
- (2022) Motahareh Arjomandnejad et al. Biomedicines
- Long noncoding RNAs in induced pluripotent stem cells and their differentiation
- (2022) Mirolyuba Ilieva et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Successful organoid-mediated generation of iPSC-derived CAR-T cells
- (2022) Shin Kaneko Cell Stem Cell
- 3D-organoid culture supports differentiation of human CAR+ iPSCs into highly functional CAR T cells
- (2022) Zhiqiang Wang et al. Cell Stem Cell
- CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
- (2022) Kevin Pan et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Engineering the next-generation of CAR T-cells with CRISPR-Cas9 gene editing
- (2022) Alexander Dimitri et al. Molecular Cancer
- iNKT: A new avenue for CAR-based cancer immunotherapy
- (2022) Yilin Liu et al. Translational Oncology
- Induced CAR-Macrophages as a Novel Therapeutic Cell Type for Cancer Immune Cell Therapies
- (2022) Siyu Su et al. Cells
- CAR-NK cells for cancer immunotherapy: from bench to bedside
- (2022) Leisheng Zhang et al. Biomarker Research
- EZH1 repression generates mature iPSC-derived CAR T cells with enhanced antitumor activity
- (2022) Ran Jing et al. Cell Stem Cell
- CAR-T Cell Therapy in Hematological Malignancies: Current Opportunities and Challenges
- (2022) Xiaomin Zhang et al. Frontiers in Immunology
- Generation of T-cell-receptor-negative CD8αβ-positive CAR T cells from T-cell-derived induced pluripotent stem cells
- (2022) Sjoukje J. C. van der Stegen et al. Nature Biomedical Engineering
- Development of a human phage display-derived anti-PD-1 scFv antibody: an attractive tool for immune checkpoint therapy
- (2022) Sepideh Safaei Ghaderi et al. BMC BIOTECHNOLOGY
- Immunovirotherapy: The role of antibody based therapeutics combination with oncolytic viruses
- (2022) Mahdie Jafari et al. Frontiers in Immunology
- Next generations of CAR-T cells - new therapeutic opportunities in hematology?
- (2022) Jaromir Tomasik et al. Frontiers in Immunology
- DLL4 and VCAM1 enhance the emergence of T cell–competent hematopoietic progenitors from human pluripotent stem cells
- (2022) Yale S. Michaels et al. Science Advances
- CAR-T cell potency: from structural elements to vector backbone components
- (2022) Marzieh Mazinani et al. Biomarker Research
- Interim Phase I Clinical Data of FT819-101, a Study of the First-Ever, Off-the-Shelf, iPSC-Derived TCR-Less CD19 CAR T-Cell Therapy for Patients with Relapsed/Refractory B-Cell Malignancies
- (2022) Amitkumar Mehta et al. BLOOD
- Optimization of the proliferation and persistency of CAR T cells derived from human induced pluripotent stem cells
- (2022) Tatsuki Ueda et al. Nature Biomedical Engineering
- SV40 large T antigen-induced immortalization reprograms mouse cardiomyocyte progenitors with mesenchymal stem cell characteristics and osteogenic potential
- (2022) Yichun Yu et al. Genes and Diseases
- A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy
- (2021) Shoichi Iriguchi et al. Nature Communications
- Direct cell reprogramming: approaches, mechanisms and progress
- (2021) Haofei Wang et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Induced pluripotent stem cell technology: trends in molecular biology, from genetics to epigenetics
- (2021) Amirhosein Maali et al. Epigenomics
- CAR-T cell therapy: current limitations and potential strategies
- (2021) Robert C. Sterner et al. Blood Cancer Journal
- The CD28-Transmembrane Domain Mediates Chimeric Antigen Receptor Heterodimerization With CD28
- (2021) Yannick D. Muller et al. Frontiers in Immunology
- Generation of hypoimmunogenic T cells from genetically engineered allogeneic human induced pluripotent stem cells
- (2021) Bo Wang et al. Nature Biomedical Engineering
- CAR-macrophage: A new immunotherapy candidate against solid tumors
- (2021) Yizhao Chen et al. BIOMEDICINE & PHARMACOTHERAPY
- Macrophage Polarization States in the Tumor Microenvironment
- (2021) Ava J. Boutilier et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- DL4-μbeads induce T cell lineage differentiation from stem cells in a stromal cell-free system
- (2021) Ashton C. Trotman-Grant et al. Nature Communications
- Cellular reprogramming and epigenetic rejuvenation
- (2021) Daniel J. Simpson et al. Clinical Epigenetics
- Induced Pluripotent Stem Cells (iPSCs)—Roles in Regenerative Therapies, Disease Modelling and Drug Screening
- (2021) Mourad A. M. Aboul-Soud et al. Cells
- Chemistry of Lipid Nanoparticles for RNA Delivery
- (2021) Yulia Eygeris et al. ACCOUNTS OF CHEMICAL RESEARCH
- Prospects for Development of Induced Pluripotent Stem Cell-Derived CAR-Targeted Immunotherapies
- (2021) Roberta Mazza et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Mucosal-associated invariant T (MAIT) cells, a new source of universal immune cells for chimeric antigen receptor (CAR)-cell therapy
- (2021) Armelle Bohineust et al. BULLETIN DU CANCER
- The transcription factor code in iPSC reprogramming
- (2021) Weixian Deng et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- CAR T-cell therapy for B-cell lymphoma
- (2021) Nathan Denlinger et al. CURRENT PROBLEMS IN CANCER
- Improving CAR T-Cell Persistence
- (2021) Violena Pietrobon et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Role of epigenetics in cellular reprogramming; from iPSCs to disease modeling and cell therapy
- (2021) Yong Li et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Generation of highly proliferative, rejuvenated cytotoxic T cell clones through pluripotency reprogramming for adoptive immunotherapy
- (2021) Yohei Kawai et al. MOLECULAR THERAPY
- Dual-antigen targeted iPSC-derived chimeric antigen receptor-T cell therapy for refractory lymphoma
- (2021) Sakiko Harada et al. MOLECULAR THERAPY
- Advances in Adoptive Cell Therapy Using Induced Pluripotent Stem Cell-Derived T Cells
- (2021) Ratchapong Netsrithong et al. Frontiers in Immunology
- Advances in Universal CAR-T Cell Therapy
- (2021) Haolong Lin et al. Frontiers in Immunology
- CAR-NK Cells: From Natural Basis to Design for Kill
- (2021) Muhammad Babar Khawar et al. Frontiers in Immunology
- Clever Experimental Designs: Shortcuts for Better iPSC Differentiation
- (2021) Ryota Yasui et al. Cells
- Glypican-3–Specific CAR T Cells Coexpressing IL15 and IL21 Have Superior Expansion and Antitumor Activity against Hepatocellular Carcinoma
- (2020) Sai Arun Batra et al. Cancer Immunology Research
- MAIT Cells Come to the Rescue in Cancer Immunotherapy?
- (2020) Zuzanna Lukasik et al. Cancers
- Cord Blood CAR-NK Cells: Favorable Initial Efficacy and Toxicity but Durability of Clinical Responses Not Yet Clear
- (2020) Anastasios Karadimitris CANCER CELL
- Targeting the 4-1BB costimulatory molecule through single chain antibodies promotes the human T-cell response
- (2020) Salman Bagheri et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- Recent insights of T cell receptor-mediated signaling pathways for T cell activation and development
- (2020) Jeong-Ryul Hwang et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Gene modification strategies for next-generation CAR T cells against solid cancers
- (2020) Yonggui Tian et al. Journal of Hematology & Oncology
- Hinge and Transmembrane Domains of Chimeric Antigen Receptor Regulate Receptor Expression and Signaling Threshold
- (2020) Kento Fujiwara et al. Cells
- Cluster of differentiation 19 chimeric antigen receptor T‑cell therapy in pediatric acute lymphoblastic leukemia (Review)
- (2020) Zexin Fu et al. Oncology Letters
- Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson’s disease
- (2020) Daisuke Doi et al. Nature Communications
- Gamma-Delta CAR-T Cells Show CAR-Directed and Independent Activity Against Leukemia
- (2020) Meir Rozenbaum et al. Frontiers in Immunology
- Co-Expression of IL-7 Improves NKG2D-Based CAR T Cell Therapy on Prostate Cancer by Enhancing the Expansion and Inhibiting the Apoptosis and Exhaustion
- (2020) Cong He et al. Cancers
- Neurotoxicity and Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy: Insights Into Mechanisms and Novel Therapies
- (2020) Elizabeth L. Siegler et al. Frontiers in Immunology
- iPS cell-based therapy for Parkinson's disease: A Kyoto trial
- (2020) Jun Takahashi Regenerative Therapy
- Differentiation of human induced pluripotent stem cells into erythroid cells
- (2020) Mohsen Ebrahimi et al. Stem Cell Research & Therapy
- Engineering better chimeric antigen receptor T cells
- (2020) Hao Zhang et al. Experimental Hematology & Oncology
- Lymphocytes in Cellular Therapy: Functional Regulation of CAR T Cells
- (2019) Dwivedi Alka et al. Frontiers in Immunology
- T cell engineered with a novel nanobody‐based chimeric antigen receptor against VEGFR2 as a candidate for tumor immunotherapy
- (2019) Fatemeh Hajari Taheri et al. IUBMB LIFE
- Targeted Disruption of HLA Genes via CRISPR-Cas9 Generates iPSCs with Enhanced Immune Compatibility
- (2019) Huaigeng Xu et al. Cell Stem Cell
- Generation of hypoimmunogenic human pluripotent stem cells
- (2019) Xiao Han et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Recent Updates on Induced Pluripotent Stem Cells in Hematological Disorders
- (2019) Methichit Wattanapanitch Stem Cells International
- The cell cycle in stem cell proliferation, pluripotency and differentiation
- (2019) Lijun Liu et al. NATURE CELL BIOLOGY
- Next-generation regulatory T cell therapy
- (2019) Leonardo M. R. Ferreira et al. NATURE REVIEWS DRUG DISCOVERY
- Engineering γδT cells limits tonic signaling associated with chimeric antigen receptors
- (2019) Jonathan Fisher et al. Science Signaling
- A Three-dimensional Thymic Culture System to Generate Murine Induced Pluripotent Stem Cell-derived Tumor Antigen-specific Thymic Emigrants
- (2019) Raul Vizcardo et al. Jove-Journal of Visualized Experiments
- FT819: Translation of Off-the-Shelf TCR-Less Trac-1XX CAR-T Cells in Support of First-of-Kind Phase I Clinical Trial
- (2019) Chiawei Chang et al. BLOOD
- Guided Polarization of iPSC-Derived CD4SP Helper T Cells By CRISPR/Cas9-Based Genome-Editing
- (2019) Hisashi Yano et al. BLOOD
- Notch signalling in T cell homeostasis and differentiation
- (2019) Joshua D. Brandstadter et al. Open Biology
- Optimizing Manufacturing Protocols of Chimeric Antigen Receptor T Cells for Improved Anticancer Immunotherapy
- (2019) Sophia Stock et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- CD4 Helper and CD8 Cytotoxic T Cell Differentiation
- (2018) Ichiro Taniuchi Annual Review of Immunology
- CAR T cell immunotherapy for human cancer
- (2018) Carl H. June et al. SCIENCE
- Cancer immunotherapy with CAR-T cells – behold the future
- (2018) Charlotte Graham et al. CLINICAL MEDICINE
- A Review on Leukemia and iPS Technology: Application in Novel Treatment and Future
- (2018) Amirhosein Maali et al. Current Stem Cell Research & Therapy
- NOTCH Signaling in T-Cell-Mediated Anti-Tumor Immunity and T-Cell-Based Immunotherapies
- (2018) Michelle A. Kelliher et al. Frontiers in Immunology
- Recent Advances in Anti-cancer Protein/Peptide Delivery
- (2018) Xun Liu et al. BIOCONJUGATE CHEMISTRY
- Teaching an old dog new tricks: next-generation CAR T cells
- (2018) Nicholas Tokarew et al. BRITISH JOURNAL OF CANCER
- Enhancing T Cell Receptor Stability in Rejuvenated iPSC-Derived T Cells Improves Their Use in Cancer Immunotherapy
- (2018) Atsutaka Minagawa et al. Cell Stem Cell
- Induced Pluripotent Stem Cells and Their Use in Human Models of Disease and Development
- (2018) Peter Karagiannis et al. PHYSIOLOGICAL REVIEWS
- Chimeric Antigen Receptor (CAR) Treg: A Promising Approach to Inducing Immunological Tolerance
- (2018) Qunfang Zhang et al. Frontiers in Immunology
- Regulation of Effector and Memory CD8 T Cell Differentiation by IL-2—A Balancing Act
- (2018) Vandana Kalia et al. Frontiers in Immunology
- Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection
- (2017) Justin Eyquem et al. NATURE
- Haematopoietic stem and progenitor cells from human pluripotent stem cells
- (2017) Ryohichi Sugimura et al. NATURE
- Notch Signaling in T Helper Cell Subsets: Instructor or Unbiased Amplifier?
- (2017) Irma Tindemans et al. Frontiers in Immunology
- Regeneration of CD8αβ T Cells from T-cell–Derived iPSC Imparts Potent Tumor Antigen-Specific Cytotoxicity
- (2016) Takuya Maeda et al. CANCER RESEARCH
- Precision Tumor Recognition by T Cells With Combinatorial Antigen-Sensing Circuits
- (2016) Kole T. Roybal et al. CELL
- Engineering Customized Cell Sensing and Response Behaviors Using Synthetic Notch Receptors
- (2016) Leonardo Morsut et al. CELL
- Reprogramming of Melanoma Tumor-Infiltrating Lymphocytes to Induced Pluripotent Stem Cells
- (2016) Hidehito Saito et al. Stem Cells International
- TRUCKs: the fourth generation of CARs
- (2015) Markus Chmielewski et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- The pharmacology of second-generation chimeric antigen receptors
- (2015) Sjoukje J. C. van der Stegen et al. NATURE REVIEWS DRUG DISCOVERY
- Engineering CAR-T cells: Design concepts
- (2015) Shivani Srivastava et al. TRENDS IN IMMUNOLOGY
- Targeted Disruption of the β2-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells
- (2015) Dachun Wang et al. Stem Cells Translational Medicine
- A Safeguard System for Induced Pluripotent Stem Cell-Derived Rejuvenated T Cell Therapy
- (2015) Miki Ando et al. Stem Cell Reports
- IL-12 secreting tumor-targeted chimeric antigen receptor T cells eradicate ovarian tumorsin vivo
- (2015) Mythili Koneru et al. OncoImmunology
- Rescue of Notch-1 Signaling in Antigen-Specific CD8+ T Cells Overcomes Tumor-Induced T-cell Suppression and Enhances Immunotherapy in Cancer
- (2014) R. A. Sierra et al. Cancer Immunology Research
- Regeneration of Human Tumor Antigen-Specific T Cells from iPSCs Derived from Mature CD8 + T Cells
- (2013) Raul Vizcardo et al. Cell Stem Cell
- Generation of Rejuvenated Antigen-Specific T Cells by Reprogramming to Pluripotency and Redifferentiation
- (2013) Toshinobu Nishimura et al. Cell Stem Cell
- Hematopoietic stem cells for cancer immunotherapy
- (2013) Eric Gschweng et al. IMMUNOLOGICAL REVIEWS
- Of CARs and TRUCKs: chimeric antigen receptor (CAR) T cells engineered with an inducible cytokine to modulate the tumor stroma
- (2013) Markus Chmielewski et al. IMMUNOLOGICAL REVIEWS
- Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy
- (2013) Maria Themeli et al. NATURE BIOTECHNOLOGY
- The Basic Principles of Chimeric Antigen Receptor Design
- (2013) Michel Sadelain et al. Cancer Discovery
- Generating an iPSC Bank for HLA-Matched Tissue Transplantation Based on Known Donor and Recipient HLA Types
- (2012) Craig J. Taylor et al. Cell Stem Cell
- Targeting high affinity and epitope-distinct oligoclonal nanobodies to HER2 over-expressing tumor cells
- (2012) Fatemeh Rahimi Jamnani et al. EXPERIMENTAL CELL RESEARCH
- Development of Oligoclonal Nanobodies for Targeting the Tumor-Associated Glycoprotein 72 Antigen
- (2012) Zahra Sharifzadeh et al. MOLECULAR BIOTECHNOLOGY
- Mesodermal and Hematopoietic Differentiation from ES and iPS Cells
- (2012) Tomoko Inoue-Yokoo et al. Stem Cell Reviews and Reports
- Nanobody; an Old Concept and New Vehicle for Immunotargeting
- (2011) Fatemeh Rahbarizadeh et al. IMMUNOLOGICAL INVESTIGATIONS
- Reprogramming of T Cells from Human Peripheral Blood
- (2010) Yuin-Han Loh et al. Cell Stem Cell
- Reprogramming of Human Peripheral Blood Cells to Induced Pluripotent Stem Cells
- (2010) Judith Staerk et al. Cell Stem Cell
- Generation of Induced Pluripotent Stem Cells from Human Terminally Differentiated Circulating T Cells
- (2010) Tomohisa Seki et al. Cell Stem Cell
- Interleukin-2 and Inflammation Induce Distinct Transcriptional Programs that Promote the Differentiation of Effector Cytolytic T Cells
- (2010) Matthew E. Pipkin et al. IMMUNITY
- Differentiation of mesodermal cells from pluripotent stem cells
- (2010) Michinori Kitagawa et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- The Optimal Antigen Response of Chimeric Antigen Receptors Harboring the CD3 Transmembrane Domain Is Dependent upon Incorporation of the Receptor into the Endogenous TCR/CD3 Complex
- (2010) J. S. Bridgeman et al. JOURNAL OF IMMUNOLOGY
- Signaling by intrathymic cytokines, not T cell antigen receptors, specifies CD8 lineage choice and promotes the differentiation of cytotoxic-lineage T cells
- (2010) Jung-Hyun Park et al. NATURE IMMUNOLOGY
- Phosphatidylinositol 3-Kinase Signaling in Thymocytes: The Need for Stringent Control
- (2010) E. Fayard et al. Science Signaling
- ZAP-70: An Essential Kinase in T-cell Signaling
- (2010) H. Wang et al. Cold Spring Harbor Perspectives in Biology
- Differential Expression of Interleukin-17A and -17F Is Coupled to T Cell Receptor Signaling via Inducible T Cell Kinase
- (2009) Julio Gomez-Rodriguez et al. IMMUNITY
- Distinct functions for the transcription factors GATA-3 and ThPOK during intrathymic differentiation of CD4+ T cells
- (2008) Lie Wang et al. NATURE IMMUNOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started